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.2012.07.0Abstract Hops (Humulus lupulus L. Cannabaceae) is an economically important crop, that has
drawn more attention in recent years due to its potential pharmaceutical applications. Bitter acids
(prenylated polyketides) and prenylﬂavonoids are the primary phytochemical components that
account for hops resins medicinal value. We have previously reported on utilizing untargeted
NMR and MS metabolomics for analysis of 13 hops cultivars, revealing for differences in a- versus
b-bitter acids composition in derived resins. In this study, effect of ratios of bitter a- to b-acids in
hop resins to cytotoxicity of hop resins was investigated. In vitro cell culture assays revealed that
b-acids were more effective than a-acids in growth inhibition of PC3 and HT29 cancer cell lines.
Nevertheless, hop resins enriched in b-acids showed comparable growth inhibition patterns to
a-enriched resins and suggesting that bioactivity may not be easily predicted by metabolomics
and/or gross metabolic proﬁling in hops.
ª 2012 Cairo University. Production and hosting by Elsevier B.V. All rights reserved.Introduction
The hop plant (Humulus lupulus L., Cannabaceae) is an eco-
nomically important crop cultivated in most temperate zones
of the world for its female inﬂorescences, commonly referred
to as ‘‘hop cones’’ or ‘‘hops’’. The bitter, resinous substance
produced in the glandular hairs of the strobiles (lupulin glands)
is used in brewing, baking and as cattle feed for its bacteriostatic(M.A. Farag).
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06action and preservative qualities [1]. In addition, it is used in
pharmaceutical applications. The resin is used as a mild seda-
tive in European phytotherapy, and hop has been investigated
for its potent estrogenic and, more recently, potential cancer
chemopreventive activities [2,3]. Major class of secondary
metabolites in hop lupulin glands include hop bitter acids which
exhibit interesting effects on human health [4]. The hop bitter
acids are resinous alicyclic phenolic acids, classiﬁed as a-acids
(humulones) and b-acids (lupulones). The main a-acids are
humulone, cohumulone, and adhumulone; the corresponding
b-acids are lupulone, colupulone, and adlupulone (Fig. 1A).
The b-acids differ structurally from the a-acids by having one
extra isoprenyl group. Furthermore, hop resin contain terpenes
and isoprenylated ﬂavonoids [5–7]. There are at least 200
different hop varieties grown and cultivated worldwide and it
is of increasing interest to develop accurate methods for hop.V. All rights reserved.
Fig. 1 Hop a/b bitter acids composition in comparison to its cytotoxic effect. (A) Chemical structures of humulones (a-bitter acids) and
lupulones (b-bitter acids) series detected in hop resin. (B) Hierarchical cluster analysis (HCA) of hop cultivars based on group average
cluster analysis of its biochemical proﬁle as the analytical data showing clustering of cultivars in 2 major groups mostly inﬂuenced by its b-
bitter acids levels (lg/ml) and b/a-acid ratios. Data are mean ± SE from three independent measurements. Grey box highlights b-acids
enriched resins (HSE, HHE & HHT) from other cultivars. (C) Cytotoxicity data of hops resin extracts and pure a- and b-bitter acids
against human prostate (PC3) and colon (HT29) cancer cell lines (IC50 values expressed in lg/ml). Detailed description of bitter acids
standards composition is provided under materials and methods. Data are mean ± SE from four independent experiments. Note the grey
box highlighting b-enriched resins (HSE, HHE & HHT) showed no signiﬁcant difference in its IC50 values from other samples.
418 M.A. Farag and L.A. Wessjohanncharacterization that could be used to classify hop from differ-
ent geographical origins or countries. We have recently re-
ported on the use of LC–MS and NMR for the metabolic
ﬁngerprinting of hop. This comparative untargeted approach
revealed for compositional differences in a/b bitter acids amonghop cultivars [7]. Our objective from this study was to further
investigate whether differences in a- and b-bitter acids
composition in hop resins could inﬂuence its cytotoxic effect.
A total of 13 chemically well-characterized hop resins were
tested for growth inhibition effect against (mutated androgen
Hop bitter acids cytotoxic effect 419dependent) prostate (PC3) and (androgen independent) colon
(HT-29) cancer cell lines along with standard mix of a- and b-
acids. HCA multivariate data analysis was also used as an
additional exploratory tool to assess the heterogeneity and
relationship between the different hop cultivars.
Material and methods
Plant material
The 13 different hop resins included in this study were pro-
vided by Hopsteiner (Mainburg, Germany). All information
on collected samples and their origin is recorded in Table 1.
Resins were obtained by standard extraction with ethanol. A
detailed description of the resin preparation is given by [8].
Chemicals and reagents
Standard for a-acids mixture (30.06% cohumulone and
69.93% humulone + adhumulone) and b-acids mixtures
(47.95% colupulone and 52.05% lupulone + adlupulone)
were provided by Hopsteiner (Mainburg, Germany). All other
chemicals and standards were provided by Sigma Aldrich (St.
Louis, MO, USA).
HCA analysis of LC/MS dataset
Quantiﬁed hop metabolites performed using XCMS data anal-
ysis software [9] was imported into the R 2.9.2 software pack-
age using custom-written procedures for hierarchical clustering
analysis (HCA) to visualize for general clustering trends.
Absolute LC/MS peak area values were autoscaled (the mean
area value of each feature throughout all samples was sub-
tracted from each individual feature area and the result divided
by the standard deviation) prior to clustering analysis. This
provides similar weights for all the variables. Detailed descrip-
tion on bitter acids analysis and quantiﬁcation methodology is
provided in [7].
Cell lines and culture conditions
Human prostate cancer cell line, PC3, was obtained from the
Deutsche Sammlung von Mikroorganismen und Zellkulturen,Table 1 Origins of hops cultivars harvested in 2009.
Cultivar Reg
Hallertau Perle Hal
Hallertau Hallertauer Tradition Hal
Hallertau Hersbrucker Hal
Hallertau Herkules Hal
Hallertau Hallertauer Magnum Hal
Hallertau Spalter Select Hal
Hallertau Hallertauer Taurus Hal
Elbe-Saale Magnum Elb
Elbe-Saale Northern Brewer Elb
Tettnang Perle Tett
Mu¨hlviertel Magnum Mu¨
Mu¨hlviertel Perle Mu¨
Saaz Agnus SaaBraunschweig, (DMSZ ACC# 465) and the colon cancer cell
line, HT29, was obtained from the medical immunology
department at Martin Luther-Universita¨t Halle-Wittenberg
(Prof. Seliger). The cells were grown as monolayers in adherent
cell lines and were routinely cultured in RPMI (Roswell Park
Memorial Institute) 1640 supplemented with 10% heat-inacti-
vated fetal bovine serum (FBS) and 1% L-glutamine in 75 cm2
polystyrene ﬂasks (Corning Life Sciences, UK) and maintained
at 37 C in a humidiﬁed atmosphere with 5% CO2.
Cytotoxicity assay
Cells were plated at a density of 1 · 104/well in 96-well plates.
They were allowed to attach to the plate for 24 h. After 24 h,
the media were replaced with RPMI media containing resin ex-
tracts. Four concentrations of each resins were tested (1, 5, 10
and 20 lg/ml). Resins were initially dissolved in DMSO at a
concentration of 2 mg/ml and further diluted with RPMI med-
ium. The DMSO concentration in the assay did not exceed
0.1% and was not cytotoxic to the tumor cells. After 72 h,
the growth medium was taken out and 100 ll of XTT-solution
(2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)
carbonyl]-2H-tetrazolium hydroxide) (Roche Applied Science,
Mannheim, Germany) was added to each well, and plates were
incubated at 37 C for another 4 h at a (ﬁnal concentration
0.3 mg/ml). Absorbance was measured at 490 nm against a ref-
erence wavelength at 650 nm using a microplate reader (Beck-
man Coulter, DTX 880 Multimode Reader). The mean of four
experiments for each dose was used to calculate the IC50 and
repeated in 2 passages for each cancer cell line. Digitonin
was used as a standard cytotoxic agent with an IC50 value of
1.7 lg/ml. IC50 values were calculated with GraphPad Prism
version 5 software, using sigmoidal dose–response function.
Results and discussion
Hierarchical cluster analysis (HCA) of hop resins
The major goal of this study was to investigate the effect of
hop bitter acids compositional differences on hop resin cyto-
toxic effect. To accomplish this goal, we have selected a study
group of resins derived from 13 hop cultivars, 10 of which orig-
inated from Germany and 3 others originated from Austria
and the Czech Republic (Table 1). Previous LC–MS andion, country Abbreviation
lertau, Germany HPE
lertau, Germany HHT
lertau, Germany HHE
lertau, Germany HHS
lertau, Germany HHM
lertau, Germany HSE
lertau, Germany HTU
e-Saale, Germany EHM
e-Saale, Germany ENB
nang, Germany TPE
hlviertel, Austria ATHM
hlviertel, Austria ATPE
z, Czech Republic CZAG
420 M.A. Farag and L.A. WessjohannNMR analyses revealed the compositional differences in a and
b-bitter acids among resins derived from different hop culti-
vars [7]. Hop cultivars HHS, HTU & HHM were found to
be enriched in a-acids, whereas higher levels of b-acids were
determined in cultivar HHE, and to less extent in HSE and
HHT as conﬁrmed by absolute metabolites quantiﬁcation [7].
Hierarchical cluster analysis (HCA) is an unsupervised data
analysis method that allows interpretation of metabolites results
in a fairly intuitive graphical way without prior knowledge of the
sample composition. In this study, HCA of the different hop res-
ins based on quantiﬁed data from a total of 29 metabolites de-
scribed by Farag et al. [7] was used as an additional exploratory
tool to assess the heterogeneity among the different hop cultivars.
HCA showed two clear major clusters, of 10 and 3 cultivars
(Fig. 1B), referred to as groups I and II, respectively. Clustering
pattern was mostly inﬂuenced by differences in bitter acids levels
among cultivars as revealed from density of corresponding signal
in the heatmap plot (data not shown). Inspection of group II
showed that HHE, HHT and HSE cultivars are more closely re-
lated as in both lupulone type b-acids were enriched (260–350 lg/
mg resin dry wt.) and in agreement with PCA results [7]. Cluster I
included all other cultivars having a lower levels in b-acids reach-
ing an average of 170 to 260 lg/mg resin dry wt. Interestingly,
both ATHM and ATPE cultivars that were collected from the
same geographical area/region (Austria) clustered together
(Fig. 1B) suggesting that in hop, geographical origin can be re-
ﬂected in its bitter acids composition.
It is hypothesized that in natural plant systems, metabolic
pathways contain biosynthetic modules, which lead to the for-
mation of metabolites (groups of metabolites whose produc-
tion is co-regulated and biosynthetically linked). To test
whether such co-regulated metabolite modules do exist in hops
and produce this myriad of phytochemicals, HCA analysis was
also performed (Supplementary Fig. 1) with Pearson correla-
tion coefﬁcients calculated for all pairs of 29 metabolites iden-
tiﬁed in our analysis [7]. The HCA results and ‘correlation
heatmaps’ clearly show the existence of modules of co-regu-
lated metabolites in hops, supporting the hypothesis that bio-
synthetic modules do indeed exist in natural plant systems [10].
Metabolites within the same module had abundance patterns
across cultivars that were highly correlated with each other,
and they had similar relationships to other compounds. Impor-
tantly, one of the many co-regulated metabolite modules that
were readily detected in this clustering analysis contained the
unprenylated ﬂavonoids i.e. quercetin and kaempferol (module
B) whereas prenylated metabolites belonged to separate
metabolite modules. The presence of a-bitter acids in a sepa-
rate module (module C) from b-forms (module D) suggests
the presence of a distinct isoprenyl transferase in hops catalyz-
ing for the attachment of an extra isoprenyl group (Fig. 1) as
the last step of b-acids biosynthesis. Cloning and or functional
characterization of isoprenyl transferases involved in bitters
acids biosynthesis has yet to be achieved. It should be noted
that b-bitter acids oxidative products i.e. cohulupone and
hulupone were clustered in a separate metabolite (module A)
along with other unknown metabolites. This is the ﬁrst report
on metabolites modules existence in hop plants.
Hop resin cytotoxic effect in relation to a/b bitter acid levels
Increasing evidence in the literature points towards the marked
cytotoxic effect found for hop bitter acids in addition to thewell established effects of xanthohumol and 8-prenylnaringe-
nin [11,4]. Analyses of resins in the current study show that
xanthohumol was present at much lower levels compared to
bitter acids (ca. 30 ug/mg resin dry wt.) whereas 8-prenylna-
ringenin was found at trace levels. Recently, both humulone
and lupulone isolates were found to inhibit cancer cell growth
with lupulone exhibiting lower IC50 values against lung and
breast cancer cell lines [12]. Cytotoxic effect in hop is mediated
via angiogenesis, inducing apoptosis, and by increasing the
expression of cytochrome P450 detoxiﬁcation enzyme [4].
Our objective was to investigate cytotoxic effect of hop resins
derived from the 13 cultivars with different a-/b-acids compo-
sition as revealed from our HCA analysis. The 13 hop resins
were tested for growth inhibition effect against (mutated
androgen dependent) prostate (PC3) and (androgen indepen-
dent) colon (HT29) cancer cell lines along with standard mix
of a- and b-acids. IC50 values exhibited are presented in
Fig. 1C. All hop resin extracts inhibited cancer cell growth
with comparable IC50 values ranging from 9 to 20 lg/ml for
HT29 and PC3 cell lines. Both a/b bitter acid standards exhib-
ited high cytotoxic activities against both PC3 and HT29 cells.
However, IC50 values for b-acids (lupulones: PC3, 2.4 lg/ml;
HT29, 8.1 lg/ml) were signiﬁcantly lower than the a acids
(humulones: PC3, 13.2 lg/ml; HT29, 15.5 lg/ml). These results
were in agreement with previous results [12]. It is unclear
though, whether differences are based on difference in lipophil-
icity due to extra isoprenyl group in b-acids (and thus cell up-
take), or rather a speciﬁc target effect. Interestingly,
prenylation of apigenin and liquiritigenin ﬂavonoids was
found to enhance its cytotoxicity against rat H4IIE hepatoma
and C6 glioma cells [13]. Nevertheless, cultivars such as HSE,
HHE and HHT enriched in b-acids (clustered separately in
group II, Fig. 1B) did not exhibit a lower IC50 values against
both cell lines compared with other cultivars. This might be
attributed to the small differences between a- and b-acids levels
among cultivars. In addition, other compounds of higher spe-
ciﬁc activity i.e. xanthohumol and 8-prenyl naringenin (8-PN)
present in the hop matrix [14–16] may act additively or syner-
gistically, and may eventually be more relevant for the cyto-
toxic or speciﬁcity effects of hop resin extracts than just the
high concentrations (75% resin content) of bitter acids. These
results suggest that anticancer activity may not be easily pre-
dicted by multivariate data analysis of metabolites composi-
tion in hop. In contrast to the compound related differences,
there is a consistent differentiation according to the cell type,
with PC3 being more sensitive than HT29, which is opposite
to the common response of these cell lines on cytotoxic com-
pounds. The origin of this trend is unclear, but PC3 cells are
more responsive to steroid mimetics as found in hop. In con-
clusion, our results conﬁrm the potential health beneﬁts of
hops in chemoprevention, however no correlation could be ob-
served between differences in hop bitter acids composition and
anticancer effect among hop cultivars and suggesting that bio-
activity may not be easily predicted by bitter acids proﬁling in
hops.Acknowledgments
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